Patent · US Active

S. agalactiae antigens I and II

US8952135B2 · kind B2 · utility

0Cited by

7References

11Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Andreas Meinke · Pressbaum, AT
Eszter Nagy · Wien, AT
Markus Hanner · Pressbaum, AT
Markus Horky · Wien, AT
Sabine Kallenda · Wien, AT
Sonja Prustomersky · Wien, AT

Key dates

Filing date	May 6, 2013
Grant date	Feb 10, 2015
Priority date	—
Expiry date	May 6, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. agalactiae, and methods for isolating such antigens and specific uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.